THE CLINICAL ONCOLOGY EXPERTS

We apply our extensive medical and industry expertise to provide integrated, strategic, and comprehensive clinical drug development consulting services to the biopharmaceutical industry.

Continue

The Challenge

As our population ages and cancer incidence rates continue to rise, so, too, does investment in cancer drug development. This, in turn, leads to increased demand for experienced oncologists with executive-level industry experience. While oncology companies require seamless clinical interface and leadership, many are either not yet in a position to hire a full-time Chief Medical Officer or find themselves rate-limited by the often time-consuming search for the right fulltime CMO.

The Solution

CMO Consulting provides its clients with the transitional support they require, including immediate clinical interface needed to maintain momentum and keep clinical programs on track.

About Us

The Clinical Oncology Experts

CMO Consulting is a team of highly-experienced medical oncology experts providing integrated, strategic, and comprehensive clinical drug development consulting services to the biopharmaceutical industry. We apply our extensive medical and industry expertise to provide superior CMO leadership for our clients – developing and executing clinical strategies while building organizational structure and capacity for the future.

 

 
 
 
 
our expertise

Strategic and Executional Expertise

Recognized leaders in the field, CMO Consulting provides its clients – ranging from blue-chip venture capital firms to start-ups and established biotechnology companies – access to senior level medical executives with extensive academic and industry experience. CMO leadership is focused on the development and execution of clinical strategy, company representation with key audiences, and the development of clinical infrastructure and capacity.

Track Record of Success

CMO Consulting is led by Edward Garmey, M.D., a former academic hematologist-oncologist at Memorial Sloan-Kettering Cancer Center with a successful industry track record comprising over a decade of senior leadership experience including seven prior CMO roles. CMO Consulting provides its clients with cancer drug development strategy and expertise through every step of pipeline and drug candidate development from pre-IND drug optimization and biomarker/companion diagnostic development through global registration trials and NDA filings.

Edward Garmey, M.D.

A former academic hematologist-oncologist, Edward Garmey has served as Chief Medical Officer for leading private and public biopharmaceutical companies during his 15 years in industry. Prior to a transition into consulting in 2015, Dr. Garmey served as Chief Medical Officer and Senior Vice President at Cerulean Pharma where he oversaw the initiation of multi-national clinical trials for multiple drug programs and helped lead the company’s successful $67 MM IPO. Prior to industry, Dr. Garmey served as a pediatric hematologist-oncologist at Memorial Sloan-Kettering Cancer Center (MSKCC). He is an alumnus of Harvard and New York Universities and completed his medical training at New York’s Mount Sinai Medical Center, the Children’s Hospital of Los Angeles and MSKCC. Dr. Garmey completed additional research fellowships at the National Institutes of Health and the Botswana-Harvard Partnership for H.I.V. Research in Gaborone, Botswana and he is the recipient of the young investigators awards from the American Society of Hematology and the American Heart Association. Dr. Garmey resides in the Boston area where he serves as an adjunct instructor at Harvard Medical School’s Graduate Program in Therapeutic Science and as a member of the Board of Overseers at the Beth Israel Deaconess Medical Center.

our services

CMO Consulting provides its clients with a full range of clinical services including:

  • Pre-IND drug optimization and biomarker/companion diagnostic development
  • Phase 1-2 clinical trial design and investigator/site recruitment
  • Design and oversight of global registration studies
  • Regulatory interface including filings, meetings, and breakthrough therapy designation applications
  • Global patient recruitment strategies (including niche settings of high unmet medical need)
  • Recruitment and interface with key academic opinion leaders (KOLs)
  • Oversight of pharmacovigilance, data management, and clinical operations teams
  • Scientific and medical affairs management including recruitment of scientific and medical advisory boards
  • Recruitment of high performing teams
  • Preparation and placement of manuscripts and conference presentations
  • Executive level interface with boards of directors and corporate partners
  • Clinical liaison with investor community including representation at key financing events
how we work

How We Work

  • Terms of service are client specific, typically ranging between 6-12 months.
  • Given our extensive experience, on-boarding and start-up occurs quickly. Thereafter, real-time and material leadership is provided, including immediate interface with clinical staff and vendors, R&D and executive teams, boards of advisors, and investor syndicates.
  • CMO Consulting also works in partnership with client recruiting firms to place full-time CMO successors, ensuring a seamless transition process throughout.
our clients

Clients and organizations with whom CMO Consulting’s founder, Edward Garmey, has been affiliated:

Learn more about how
CMO Consulting can help you

Contact Us

Edward Garmey, M.D.

+1 617.650.9313 | edward@CMOConsulting.com

Back to Top